Steven Cohen Jazz Pharmaceuticals PLC Put Options Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $575,950 - $663,850	-5,000 Reduced 42.02%	6,900 $830,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $457,040 - $544,000	-4,000 Reduced 25.16%	11,900 $1.46 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $1.94 Million - $2.31 Million	15,900 New	15,900 $2.06 Million
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $1.98 Million - $2.28 Million	-15,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $1.92 Million - $2.26 Million	15,800 New	15,800 $2.26 Million

503

58.1M

170K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.01B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.